文献速递胃肠外科围术期管理与 ERAS

先天性膈疝微创手术的演变:日本全国多中心回顾性队列分析

Evolution of minimally invasive surgery for congenital diaphragmatic hernia: a nationwide multicenter retrospective cohort analysis in Japan.
PubMed 文献 · Surg Endosc · 2026-06-15

本研究分析日本15个三级中心2007–2023年1081例先天性膈疝(CDH)婴儿,比较微创与开放手术的时代变化。2017年全国方案实施后,MIS转开放率从29%降至10%,完全MIS组出院复发率从8.2%降至1.0%,7天内脱机率从20%升至58.3%。

要点

  • 全国方案实施后,CDH微创手术转开放率显著下降(29%→10%)。
  • 完全MIS组出院复发率显著降低(8.2%→1.0%),开放组无变化。
  • 晚期MIS组7天内脱机率更高(20%→58.3%),呼吸恢复更早。

核心结论

  • 全国性方案实施后,MIS在经生理严重度仔细筛选的新生儿中已成为安全有效的开放手术替代方案。
  • 患者选择优化、技术熟练度稳定及围术期管理进步共同促成呼吸恢复更早和复发率显著降低。

研究设计与样本

  • 多中心回顾性队列研究,纳入日本15个三级中心2007–2023年接受确定性CDH手术的1081例婴儿。
  • 按手术方式和时期分组:早期MIS(≤2016,n=62)、晚期MIS(≥2017,n=109)、早期开放(≤2016,n=536)、晚期开放(≥2017,n=374)。
  • 院内死亡在Intended-MIS组(含转开放)评估,手术结局和复发在Complete-MIS组(无转开放成功完成)评估。

主要发现

  • Intended-MIS组转开放率从早期29%显著降至晚期10%(p<0.01)。
  • 晚期MIS组较早期严重度指数更低:氧合指数<8者76.6% vs 93.3%(p=0.012);Terui分类3级者11.4% vs 1.1%(p=0.007)。
  • Complete-MIS组7天内脱机率从20%升至58.3%(p<0.001)。
  • Complete-MIS组出院时复发率从8.2%显著降至1.0%(p=0.044),开放手术组复发率无变化。
  • Intended-MIS组院内死亡率晚期降至0%(早期3.2% vs 晚期0%,p=0.252)。

关键数值与推荐

  • Intended-MIS组转开放率:早期29% vs 晚期10%(p<0.01)。
  • 晚期MIS组氧合指数<8者占93.3%,早期为76.6%(p=0.012)。
  • 晚期MIS组Terui分类3级者占1.1%,早期为11.4%(p=0.007)。
  • Complete-MIS组7天内脱机率:早期20% vs 晚期58.3%(p<0.001)。
  • Complete-MIS组出院复发率:早期8.2% vs 晚期1.0%(p=0.044);Intended-MIS组院内死亡率:早期3.2% vs 晚期0%(p=0.252)。

临床怎么用

  • 在经生理严重度(如氧合指数、Terui分类)仔细筛选的新生儿中,可考虑将MIS作为开放手术的替代方案。
  • 全国性标准化方案的实施与转开放率下降、呼吸恢复提前和复发率降低相关,支持方案化围术期管理。
  • 需注意Intended-MIS组院内死亡率晚期降至0%但差异未达统计学显著(p=0.252),应结合患者选择解读。

局限性

  • 回顾性多中心队列设计,存在选择偏倚和时代混杂。
  • 晚期MIS组患者严重度指数更低,提示患者选择变化可能影响结局比较。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery (MIS) for congenital diaphragmatic hernia (CDH) has previously been associated with higher recurrence rates and uncertain indications compared with open surgery. Since 2017, the Japanese Congenital Diaphragmatic Hernia Study Group (JCDHSG) has implemented a standardized national protocol, potentially improving perioperative management and surgical outcomes. METHODS: This multicenter retrospective study analyzed 1,081 infants who underwent definitive CDH surgery at 15 tertiary centers in Japan between 2007 and 2023. Patients were categorized by surgical approach and period: early-period MIS (≤ 2016, n = 62), late-period MIS (≥ 2017, n = 109), early-period open (≤ 2016, n = 536), and late-period open (≥ 2017, n = 374). In-hospital mortality was assessed for the "Intended-MIS" group (including conversions), while surgical outcomes and recurrence were evaluated for the "Complete-MIS" group (successfully completed procedures without conversion). RESULTS: In the Intended-MIS group, the conversion rate dropped significantly from 29% in the early period to 10% in the late period (p < 0.01). Compared with the early period, the late-period MIS group had lower severity indices (oxygenation index < 8: 76.6% vs. 93.3%, p = 0.012; Terui category 3: 11.4% vs. 1.1%, p = 0.007). In the Complete-MIS group, early postoperative recovery improved, with a higher rate of ventilator weaning within 7 days (20% vs. 58.3%, p < 0.001). The recurrence rate at discharge in the Complete-MIS group decreased significantly (8.2% vs. 1.0%, p = 0.044), while remaining unchanged in the open surgery group. In-hospital mortality in the Intended-MIS group was eliminated in the late period (3.2% vs. 0%, p = 0.252). CONCLUSIONS: Following nationwide protocol implementation, MIS for CDH has evolved into a safe and effective alternative to open surgery in carefully selected neonates. Improved patient selection based on physiologic severity, stabilization of technical proficiency, and advances in perioperative management have led to earlier respiratory recovery and a significant reduction in recurrence.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Yamoto M, Terui K, Nagata K, et al. Evolution of minimally invasive surgery for congenital diaphragmatic hernia: a nationwide multicenter retrospective cohort analysis in Japan. Surg Endosc. 2026. PMID: 42298035. doi:10.1007/s00464-026-13042-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。